Study of Bepirovirsen in Nucleos(t)Ide Analogue-treated Participants With Chronic Hepatitis B (B-Well 2)

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

871

Participants

Timeline

Start Date

December 6, 2022

Primary Completion Date

November 13, 2025

Study Completion Date

May 8, 2026

Conditions
Chronic Hepatitis BHepatitis B, Chronic
Interventions
DRUG

Bepirovirsen

Bepirovirsen will be administered.

OTHER

Placebo

Matching placebo will be administered.

Trial Locations (173)

100

GSK Investigational Site, Taipei

404

GSK Investigational Site, Taichung

704

GSK Investigational Site, Tainan City

824

GSK Investigational Site, Kaohsiung City

1023

GSK Investigational Site, Buenos Aires

GSK Investigational Site, Auckland

1229

GSK Investigational Site, Makati City

1605

GSK Investigational Site, Pasig

1797

GSK Investigational Site, Sofia

2025

GSK Investigational Site, Papatoetoe Auckland

2145

GSK Investigational Site, Westmead

3000

GSK Investigational Site, Santa Fe

3065

GSK Investigational Site, Fitzroy

3128

GSK Investigational Site, Box Hill

4002

GSK Investigational Site, Plovdiv

4029

GSK Investigational Site, Herston

4118

GSK Investigational Site, Silang

6000

GSK Investigational Site, Cebu City

6725

GSK Investigational Site, Szeged

8000

GSK Investigational Site, Székesfehérvár

8800

GSK Investigational Site, Sliven

9020

GSK Investigational Site, Varna

10126

GSK Investigational Site, Torino

15355

GSK Investigational Site, Ansan

18016

GSK Investigational Site, Granada

19104

GSK Investigational Site, Philadelphia

20010

GSK Investigational Site, Aguascalientes

20146

GSK Investigational Site, Hamburg

20157

GSK Investigational Site, Milan

20400

GSK Investigational Site, Kuala Terengganu

21061

GSK Investigational Site, Glen Burnie

25100

GSK Investigational Site, Kuantan

28006

GSK Investigational Site, Madrid

28032

GSK Investigational Site, Madrid

28046

GSK Investigational Site, Madrid

30625

GSK Investigational Site, Hanover

31059

GSK Investigational Site, Toulouse

33136

GSK Investigational Site, Miami

34010

GSK Investigational Site, Istanbul

34982

GSK Investigational Site, Ft. Pierce

35042

GSK Investigational Site, Centreville

35100

GSK Investigational Site, Izmir

35128

GSK Investigational Site, Padua

38043

GSK Investigational Site, Grenoble

41013

GSK Investigational Site, Seville

44033

GSK Investigational Site, Ulsan

46026

GSK Investigational Site, Valencia

47012

GSK Investigational Site, Valladolid

49241

GSK Investigational Site, Pusan

50009

GSK Investigational Site, Zaragoza

50200

GSK Investigational Site, Chiang Mai

54642

GSK Investigational Site, Thessaloniki

55404

GSK Investigational Site, Minneapolis

56124

GSK Investigational Site, Pisa

59100

GSK Investigational Site, Kuala Lumpur

60329

GSK Investigational Site, Frankfurt

60596

GSK Investigational Site, Frankfurt

69317

GSK Investigational Site, Lyon

75014

GSK Investigational Site, Paris

75020

GSK Investigational Site, Denison

75651

GSK Investigational Site, Paris

76031

GSK Investigational Site, Rouen

80100

GSK Investigational Site, Johor Bahru

80131

GSK Investigational Site, Napoli

80907

GSK Investigational Site, Colorado Springs

87042

GSK Investigational Site, Limoges

90033

GSK Investigational Site, Los Angeles

90127

GSK Investigational Site, Palermo

94010

GSK Investigational Site, Créteil

94115

GSK Investigational Site, San Francisco

94121

GSK Investigational Site, San Francisco

98104

GSK Investigational Site, Seattle

100015

GSK Investigational Site, Beijing

100032

GSK Investigational Site, Beijing

110029

GSK Investigational Site, New Delhi

110060

GSK Investigational Site, New Delhi

110070

GSK Investigational Site, New Delhi

130021

GSK Investigational Site, Changchun

200025

GSK Investigational Site, Shanghai

200052

GSK Investigational Site, Shanghai

208002

GSK Investigational Site, Kanpur

210003

GSK Investigational Site, Nanjing

230022

GSK Investigational Site, Hefei

310000

GSK Investigational Site, Hangzhou

310003

GSK Investigational Site, Hangzhou

361009

GSK Investigational Site, Xiamen

380009

GSK Investigational Site, Ahmedabad

400012

GSK Investigational Site, Mumbai

400022

GSK Investigational Site, Mumbai

400042

GSK Investigational Site, Chongqing

400348

GSK Investigational Site, Cluj-Napoca

410469

GSK Investigational Site, Oradea

411001

GSK Investigational Site, Pune

430022

GSK Investigational Site, Wuhan

441108

GSK Investigational Site, Nagpur

450000

GSK Investigational Site, Zhengzhou

500003

GSK Investigational Site, Secunderabad

510000

GSK Investigational Site, Guangzhou

510630

GSK Investigational Site, Guangzhou

518023

GSK Investigational Site, Shenzhen

563114

GSK Investigational Site, Zunyi

600035

GSK Investigational Site, Chennai

610072

GSK Investigational Site, Chengdu

650021

GSK Investigational Site, Kunming

682026

GSK Investigational Site, Kochi

700150

GSK Investigational Site, Kolkata

710061

GSK Investigational Site, Xi'an

800179

GSK Investigational Site, Galati

830054

GSK Investigational Site, Ürümqi

900709

GSK Investigational Site, Constanța

29043260

GSK Investigational Site, Vitória

40110160

GSK Investigational Site, Salvador

90035003

GSK Investigational Site, Porto Alegre

C1425AGC

GSK Investigational Site, Buenos Aires

C1056ABJ

GSK Investigational Site, Ciudad Autonoma de Bueno

18618-686

GSK Investigational Site, Botucatu

60430-372

GSK Investigational Site, Fortaleza

26030-380

GSK Investigational Site, Nova Iguaçu

90020-090

GSK Investigational Site, Porto Alegre

21045-900

GSK Investigational Site, Rio de Janeiro

T2N 4N1

GSK Investigational Site, Calgary

T6G 2B7

GSK Investigational Site, Edmonton

T6G 2X8

GSK Investigational Site, Edmonton

B3H 2Y9

GSK Investigational Site, Halifax

H2L 4E9

GSK Investigational Site, Montreal

H2L 4P9

GSK Investigational Site, Montreal

S4P 0W5

GSK Investigational Site, Regina

M6H 3M1

GSK Investigational Site, Toronto

Unknown

GSK Investigational Site, Liuzhou

GSK Investigational Site, Tianjin

GSK Investigational Site, Zalaegerszeg

GSK Investigational Site, Kolkata

GSK Investigational Site, Raipur

GSK Investigational Site, Kota Bharu Kelantan

GSK Investigational Site, Kota Kinabalu

GSK Investigational Site, Panama City

GSK Investigational Site, Alcorcon Madrid

030001

GSK Investigational Site, Taiyuan

115 27

GSK Investigational Site, Athens

715 00

GSK Investigational Site, Heraklion Crete

00133

GSK Investigational Site, Roma

07100

GSK Investigational Site, Sassari

918-8503

GSK Investigational Site, Fukui

730-8619

GSK Investigational Site, Hiroshima

006-8555

GSK Investigational Site, Hokkaido

060-8648

GSK Investigational Site, Hokkaido

062-8618

GSK Investigational Site, Hokkaido

920-8650

GSK Investigational Site, Ishikawa

760-8557

GSK Investigational Site, Kagawa

860-8556

GSK Investigational Site, Kumamoto

856-8562

GSK Investigational Site, Nagasaki

634-8522

GSK Investigational Site, Nara

950-1104

GSK Investigational Site, Niigata

565-0871

GSK Investigational Site, Osaka

113-8603

GSK Investigational Site, Tokyo

750-0061

GSK Investigational Site, Yamaguchi

409-3898

GSK Investigational Site, Yamanashi

80-405

GSK Investigational Site, Gdansk

41-400

GSK Investigational Site, Mysłowice

62-571

GSK Investigational Site, Żychlin

020475

GSK Investigational Site, Bucharest

030303

GSK Investigational Site, Bucharest

405-760

GSK Investigational Site, Incheon

05505

GSK Investigational Site, Seoul

06591

GSK Investigational Site, Seoul

06080

GSK Investigational Site, Badajoz

08208

GSK Investigational Site, Sabadell Barcelona

06590

GSK Investigational Site, Ankara

L7 8XP

GSK Investigational Site, Liverpool

WC1E 6JB

GSK Investigational Site, London

TS4 3BW

GSK Investigational Site, Middlesbrough

NE7 7DN

GSK Investigational Site, Newcastle upon Tyne

PL6 8DH

GSK Investigational Site, Plymouth

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT05630820 - Study of Bepirovirsen in Nucleos(t)Ide Analogue-treated Participants With Chronic Hepatitis B (B-Well 2) | Biotech Hunter | Biotech Hunter